UNC Health Rebrands Rex Health Ventures as System-Wide VC Arm

UNC Health has rebranded Rex Health Ventures as UNC Health Ventures, converting a regional corporate investment arm into a system-wide strategic capital platform with 14 years of deal experience behind it.

The Chapel Hill, North Carolina-based health system announced the move on Aug. 18, 2026. Rex Health Ventures, established in 2012, was created to invest in and partner with emerging healthcare companies. Its work has since expanded across UNC Health, connecting entrepreneurs, co-investors, clinicians and operational leaders to evaluate and adopt promising technologies.

The renamed platform will identify, invest in and collaborate with companies whose solutions align with UNC Health's mission to improve the health and well-being of North Carolinians. It is designed to generate both financial returns and strategic value while strengthening care delivery and operations.

"Novel technologies are essential to advancing the care we provide to our patients and communities," Cristy Page, MD, MPH, CEO of UNC Health and Dean of UNC School of Medicine, said in the announcement. "UNC Health Ventures gives us the opportunity to engage with promising healthcare advancements earlier, helping our clinicians evaluate new approaches to care while shaping solutions that address real-world challenges across our health system."

The funding structure keeps returns inside the institution. UNC Health Ventures is funded through UNC Health's broader investment portfolio, and all returns are reinvested into the health system to support patient care, operations, research and future innovation. Each investment undergoes rigorous due diligence with clinical and operational input and approval by a systemwide investment committee.

"UNC Health Ventures represents an important extension of our commitment to responsible stewardship and long-term value creation," said Will Bryant, chief financial officer of UNC Health. "By engaging strategically with emerging companies and technologies, we are able to support innovation that aligns with our mission while positioning the organization for future growth and sustainability."

The platform's track record spans nearly 30 early-stage companies. One of them is Reprieve Cardiovascular, which is advancing personalized fluid management for patients with acute decompensated heart failure. According to UNC Health, the technology has the potential to enhance outcomes, reduce hospital length of stay and increase capacity within health systems — a direct operational payoff for a system that operates 20 hospitals statewide.

"Partnering with UNC Health Ventures has played a pivotal role in advancing our mission to redefine care for patients with acute heart failure," said Mark Pacyna, CEO of Reprieve Cardiovascular. "Their support extends well beyond capital, providing clinical collaboration, strategic insight and real-world experience that accelerated progress toward meaningful impact for patients, clinicians and health systems."

Managing Director Anita Watkins framed the rebrand as a maturation of an established process rather than a fresh start.

"Over the past decade, our team has worked to build a disciplined and collaborative investment approach that is closely aligned with the needs of our clinicians and operational leaders," Watkins said. "This next phase reflects both the progress we've made and the opportunity ahead to deepen partnerships and support innovation that can deliver meaningful impact across the healthcare system."

The rebranding also carries a governance signal. The move aligns the platform more closely with the UNC Health brand and reinforces its role as a system-wide capability rather than a subsidiary of Rex Healthcare, the Raleigh-based hospital system UNC Health acquired in 2000. The team will continue working with physicians, clinical leaders and system stakeholders to identify investment and partnership opportunities.

For a not-for-profit academic health system facing sustained cost pressure, the model offers a dual return: equity upside and early access to technologies its clinicians can test in real settings. The structure positions UNC Health to influence product development at portfolio companies before those tools reach the broader market.